University of California San Francisco

Publications

  1. Systemic Therapy and Surgical Management of Peritoneal Mesothelioma.
    Nunez-Rocha RE, Kim AC, Adam M
    Surg Oncol Clin N Am. 2025 Apr; 34(2):253-263.; 
    PubMed
  2. ASO Author Reflections: Innovative Robot-Assisted Endoluminal Resection for Gastroesophageal Junction Leiomyomas.
    Foroutani L, Ashraf Ganjouei A, Wang JJ, Aburayya BI, Corvera C, Alseidi A, Adam MA
    Ann Surg Oncol. 2025 Feb; 32(2):1251-1252.; 
    PubMed
  3. Robotic-Assisted Endoluminal Resection of Gastroesophageal Junction Leiomyoma with Transoral Specimen Extraction: Technique, Outcome, and Safety.
    Foroutani L, Ashraf Ganjouei A, Wang J, Aburayya BI, Corvera C, Alseidi A, Adam MA
    Ann Surg Oncol. 2025 Feb; 32(2):1218-1219.; 
    PubMed
  4. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis.
    Casey M, Brown A, Romero-Hernandez F, Wang JJ, Ganjouei AA, Tozzi F, Rashidian N, Kirkwood K, Corvera C, Nakakura E, Alseidi A, Adam M
    Am J Surg. 2024 Sep; 235:115779.; 
    PubMed
  5. Reply to: Letter to Editor Regarding Article "A Machine Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using Only Preoperatively Known Data" by Yang, Yanfei et al.
    Ashraf Ganjouei A, Wang J, Alseidi A, Adam MA
    Ann Surg Oncol. 2024 Jul; 31(7):4711-4712.; 
    PubMed
  6. ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Data-Driven, Machine Learning Approach to Augment Clinical Judgement.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
    Ann Surg Oncol. 2023 Sep; 30(9):5445-5446.; 
    PubMed
  7. ASO Author Reflections: Machine Learning-Based Preoperative Prediction of Pancreatic Fistula after Pancreaticoduodenectomy.
    Ashraf Ganjouei A, Wang JJ, Romero-Hernandez F, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 11; 30(12):7764-7765.; 
    PubMed
  8. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data.
    Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Nov; 30(12):7738-7747.; 
    PubMed
  9. ASO Author Reflections: Augmenting Clinical Decision-Making Around Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Through Traditional and Machine Learning Algorithms.
    Greenberg AL, Bartlett DL, Choudry HM, Adam MA
    Ann Surg Oncol. 2023 09; 30(9):5443-5444.; 
    PubMed
  10. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
    Ann Surg Oncol. 2023 Sep; 30(9):5433-5442.; 
    PubMed
  11. ASO Author Reflections: Contemporary Management Trends in Malignant Peritoneal Mesothelioma.
    Calthorpe L, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 08; 30(8):5130.; 
    PubMed
  12. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
    Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    Ann Surg Oncol. 2023 Aug; 30(8):5119-5129.; 
    PubMed
  13. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy.
    Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA
    J Gastrointest Surg. 2023 02; 27(2):328-336.; 
    PubMed
  14. Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?
    Miller PN, Romero-Hernandez F, Conroy P, Calthorpe L, Yilma M, Mohamedaly S, Kelly YM, Feng J, Hirose K, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA
    World J Surg. 2023 03; 47(3):750-758.; 
    PubMed
  15. Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Eng OS, Monson JRT, Ruff SM, Kasumova GG, Adam MO, Obeng-Gyasi S, Pawlik TM, Kim AC
    Front Oncol. 2022; 12:970237.; 
    PubMed
  16. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Tsung A, Adam MO, Pawlik TM, Kim AC
    Ann Surg Oncol. 2023 Jan; 30(1):335-344.; 
    PubMed
  17. Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer A, AlMasri S, Winters S, Bahary N, Singhi A, Lee KK, Paniccia A, Zureikat AH
    Ann Surg Oncol. 2023 Jan; 30(1):165-174.; 
    PubMed
  18. ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer AC, Zureikat AH
    Ann Surg Oncol. 2023 01; 30(1):175-176.; 
    PubMed
  19. ASO Author Reflections: An Objective Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy.
    Conroy PC, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Mar; 29(3):1575-1576.; 
    PubMed
  20. Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.
    Conroy PC, Calthorpe L, Lin JA, Mohamedaly S, Kim A, Hirose K, Nakakura E, Corvera C, Sosa JA, Sarin A, Kirkwood KS, Alseidi A, Adam MA
    Ann Surg Oncol. 2022 Mar; 29(3):1566-1574.; 
    PubMed
  21. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
    Adam MA, Paniccia A
    Ann Surg Oncol. 2021 Jul; 28(7):3808-3809.; 
    PubMed
  22. Development of stability-indicating methods for cefquinome sulphate.
    Shantier SW, Gadkariem EA, Adam MO, Mohamed MA
    Int J Biomed Sci. 2013 Sep; 9(3):162-7.; 
    PubMed